Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
about
sameAs
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expressionA reflection on HIV/AIDS research after 25 yearsHIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populationsThe first postmodern pandemic: 25 years of HIV/ AIDSOrigins of HIV and the AIDS pandemicRecognition of 5'-terminal TAR structure in human immunodeficiency virus-1 mRNA by eukaryotic translation initiation factor 2.Visna virus encodes a post-transcriptional regulator of viral structural gene expressionThe Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequenceEffect of mutations affecting the p6 gag protein on human immunodeficiency virus particle releaseEarly molecular replication of human immunodeficiency virus type 1 in cultured-blood-derived T helper dendritic cellsAbsolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytesUnrecognized "AIDS" in Monkeys, 1969-1980: Explanations and ImplicationsThe treatment of patients with HIVHow SAMHD1 changes our view of viral restriction3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitroRole of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1100 years of Rous sarcoma virusTrans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA virusesHuman immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationThe gene encoding the T-cell surface protein T4 is located on human chromosome 12Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1Structural features in TAR RNA of human and simian immunodeficiency viruses: a phylogenetic analysisPathogenesis of human immunodeficiency virus infectionRole of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virionsRole of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeatBiosynthesis and processing of human immunodeficiency virus type 1 envelope glycoproteins: effects of monensin on glycosylation and transportAntibody-dependent and antibody-independent complement-mediated enhancement of human immunodeficiency virus type 1 infection in a human, Epstein-Barr virus-transformed B-lymphocytic cell lineGene transfer into human lymphocytes by a defective human immunodeficiency virus type 1 vectorHuman immunodeficiency virus vpr product is a virion-associated regulatory proteinT helper cell activation and human retroviral pathogenesisMechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitroRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsTwo orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infectionConstruction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genesThe basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assemblyDarunavir, a conceptually new HIV-1 protease inhibitor for the treatment of drug-resistant HIVAn Accurate Confirmation of Human Immunodeficiency Virus Type 1 (HIV-1) and 2 (HIV-2) Infections with a Dot blot assay Using Recombinant p24, gp41, gp120 and gp36 Antigens.The HIV vaccine sagaPhosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription
P2860
Q21245193-24A12BFC-964E-4F13-B760-A5C85031466EQ21245200-57616872-DBED-4D6D-8454-1842416B4B16Q22242275-A9777329-00AA-4482-9D16-84F50DD1EB8DQ22242619-CBF3707F-9ED1-4CD1-8F0D-516FD46D7B67Q22242661-FF7E9B7F-206D-4EF6-94A3-EBBB94577A9BQ24515333-7C5C7A85-A5B6-4527-8624-BCD8D624FE07Q24557218-D7581142-F9A3-48DF-B480-BB518C4DCEF7Q24561727-671A062D-1B62-4BFF-A7DB-AFCC65600E1FQ24563651-D0AC0EE2-D4D6-4E03-B6F4-AAD5D9E0130DQ24564622-A17C4359-714F-4FF1-80D7-A2BF6E560887Q24568326-71E642DC-26E3-43B8-9156-95CB49AF495EQ24570090-0D6D0F85-2748-4C50-8692-C4C16270E142Q24597485-9AD0F778-5350-4288-914D-015EDA6CAB9FQ24605899-2ED6E0F2-95BE-423C-9ED9-7FFD1863DC7AQ24609215-1B63C5D6-E998-4CE7-910B-AC3F0823574DQ24609814-D9A1434C-C677-4E13-BA81-8804000B0152Q24610856-58FDD480-BB7B-439B-8580-51B29DEAB09EQ24627466-3649C907-11AC-4BF9-82A0-A1FC72F91A25Q24627627-39D83FFD-90DE-4EC9-B6CC-0A22CA39391DQ24628899-EB05EB88-B029-4C8F-B37D-161613D4A695Q24628991-62C7FBDC-6750-49F5-A1EC-71E276DD9240Q24630462-6572536E-F64D-4B51-9CB3-94F5903BD6E3Q24634681-11F3CC6F-6F9D-4AD9-B65C-4454C503D2A1Q24643931-7BD09CC5-CF0B-405D-9B71-34E0E3A19783Q24645417-4EC27803-9C77-49B0-A628-5F7ADEC618B6Q24645992-67D190F9-69D6-4372-BC14-B3B3B8F0799CQ24646043-0CD590BB-06DB-4CFC-BF36-2BF7CECB7D68Q24647756-0BF9E106-1227-411E-980B-94699B011477Q24647777-77E66089-373E-4E5C-95FC-ABE128AA85B8Q24649600-B8A8E2E5-1490-41B3-A9E0-2D4D34295C11Q24650854-64DE3ADE-58BF-453B-A86C-49EB26EF3538Q24650946-2A7A818B-E340-4B0A-B7E8-291827C8A34AQ24651506-74650D7D-6572-4690-9195-52A55A0F71EBQ24652969-5563E626-A7F7-4F26-869A-BEA188CBAEB0Q24655892-6819DA47-E39A-4D05-9FBA-C6AF56A14D5FQ24656044-9C245EA3-83BE-4886-AE2E-2FF249BCF3C4Q24681002-8AA3BF03-85B7-4429-B3B9-074804C0073BQ24791338-5468D836-CDF0-4642-9DA3-3609D39B14DDQ24805100-821CA85F-3306-45AF-A842-ED9B96639261Q24806541-0B86EABA-136D-4AC3-9B39-211947CB93C5
P2860
Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)
description
1983 nî lūn-bûn
@nan
1983 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@ast
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en-gb
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@nl
type
label
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@ast
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en-gb
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@nl
prefLabel
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@ast
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en-gb
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@nl
P2093
P50
P921
P3181
P356
P1433
P1476
Isolation of a T-lymphotropic ...... une deficiency syndrome (AIDS)
@en
P2093
C Axler-Blin
J. Chermann
M T Nugeyre
M. Nugeyre
S Chamaret
W Rozenbaum
P3181
P356
10.1126/SCIENCE.6189183
P407
P50
P577
1983-05-20T00:00:00Z